Your prediction
Pros and Cons of Taro Pharmaceutical Industries Ltd in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Taro Pharmaceutical Industries Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries Ltd | - | - | - | - | - | - | - |
| Opko Health Inc. | 0.720% | -2.592% | -12.455% | -37.524% | -10.383% | 2.853% | -74.712% |
| Amicus Therapeutics Inc. | 0.000% | 0.833% | 0.000% | 41.520% | 0.833% | 1.544% | 21.000% |
| Viatris Inc. | -0.150% | 1.581% | 19.690% | 25.418% | 28.097% | 24.585% | 5.430% |
Comments
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat